[Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine].
The cold-adapted, temperature sensitive and attenuated influenza master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/ 60/69 were used to generate the vaccine viruses to be included in live attenuated influenza vaccine. These vaccine viruses typically are 6:2 reassortant viruses containing the surface antigens hemagglutinin and neuraminidase of current wild type influenza A and influenza B viruses with the gene segments encoding the internal viral proteins, and conferring the cold-adapted, temperature sensitive and attenuated phenotype, being inherited from the master donor viruses. The 6:2 reassortant viruses were selected from co-infections between master donor virus and wild type viruses that theoretically may yield as many as 256 combinations of gene segments and thus 256 genetically different viruses. As the time to generate and isolate vaccine viruses is limited and because only 6:2 reassortant viruses are allowed as vaccine viruses, screening needs to be both rapid and unambiguous. The screening of the reassortant viruses by RT-PCRs using master donor virus and wild type virus specific primer sets was described to select both influenza A and influenza B 6:2 reassortant viruses to be used in seasonal and pandemic live attenuated vaccine.
I V
IV
Kiseleva
J T M
JT
Voeten
L C P
LC
Teley
N V
NV
Larionova
I A
IA
Dubrovina
Zh A
ZhA
Berdygulova
E A
EA
Bazhenova
H
H
van den Bosch
J G M
JG
Heldens
L G
LG
Rudenko
D000818:Animals; D002642:Chick Embryo; D060085:Coinfection / Q000821:virology; D016679:Genome, Viral / Q000235:genetics*; D006388:Hemagglutinins / Q000235:genetics; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000235:genetics* / Q000276:immunology; D053122:Influenza A Virus, H3N2 Subtype / Q000235:genetics* / Q000302:isolation & purification; D009981:Influenza B virus / Q000235:genetics* / Q000276:immunology; D007252:Influenza Vaccines / Q000235:genetics*; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control*; D009439:Neuraminidase / Q000235:genetics; D058873:Pandemics; D012313:RNA / Q000235:genetics / Q000302:isolation & purification; D016865:Reassortant Viruses / Q000235:genetics* / Q000276:immunology; D014613:Vaccines, Attenuated / Q000235:genetics / Q000276:immunology
D006388:Hemagglutinins; D007252:Influenza Vaccines; D014613:Vaccines, Attenuated; D012313:RNA; D009439:Neuraminidase